Advertisement
UK markets close in 1 hour 54 minutes

  • FTSE 100

    7,834.08
    -42.97 (-0.55%)
     

  • FTSE 250

    19,313.93
    -136.74 (-0.70%)
     

  • AIM

    743.22
    -2.07 (-0.28%)
     

  • GBP/EUR

    1.1679
    -0.0004 (-0.03%)
     

  • GBP/USD

    1.2467
    +0.0029 (+0.23%)
     

  • Bitcoin GBP

    52,045.02
    +1,939.26 (+3.87%)
     

  • CMC Crypto 200

    1,334.09
    +21.46 (+1.64%)
     

  • S&P 500

    5,006.15
    -4.97 (-0.10%)
     

  • DOW

    37,845.63
    +70.25 (+0.19%)
     

  • CRUDE OIL

    82.48
    -0.25 (-0.30%)
     

  • GOLD FUTURES

    2,395.40
    -2.60 (-0.11%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,716.36
    -121.04 (-0.68%)
     

  • CAC 40

    8,012.84
    -10.42 (-0.13%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Reckitt Benckiser says pharma review ongoing

Reuters - UK Focus

LONDON, Feb 12 (Reuters) - Reckitt Benckiser Group said on Wednesday the strategic review of its pharmaceuticals business was ongoing and that it would update investors over the course of the year.

The company said in October it was considering all options for the business, which could include selling it, spinning it off, or keeping it.

Regarding acquisitions, Chief Executive Rakesh Kapoor said Reckitt would continue to be active in the consumer health space, but declined to comment specifically on reports that consumer companies have approached U.S. drugmaker Merck (Dusseldorf: 6MK.DU - news) & Co about its consumer business.